Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis
NCT: NCT07583342 · ENROLLING_BY_INVITATION
광고
NCT IDNCT07583342
상태ENROLLING_BY_INVITATION
시작일2025-12-08
SponsorNorthwell Health (OTHER)
First posted
Last updated
간략 요약
The goal of this study is to learn if Relizorb, a fat-digesting enzyme, can improve tolerance of tube feeds in adult patients with moderate to severe pancreatitis. The main question it aims to answer is: Does Relizorb allow more nutrition to be delivered to participants than they received without it? Participants will be observed with standard, universal monitoring after adding Relizorb to their nutrition regimen.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.